Search results for " covid-19."

showing 10 items of 453 documents

How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency?

2020

The COVID-19 outbreak, in a few weeks, overloaded Italian hospitals, and the majority of medical procedures were postponed. During the pandemic, with hospital reorganization, clinical and learning activities performed by residents suffered a forced remodulation. The objective of this study is to investigate how urology training in Italy has been affected during the COVID-19 era. In this multi-academic study, we compared residents' training during the highest outbreak level with their previous activity. Overall 387 (67.1%) of the 577 Italian Urology residents participated in a 72-h anonymous online survey with 36 items sent via email. The main outcomes were clinical/surgical activities, soci…

Telemedicinemedicine.medical_specialtyMultivariate analysisCoronavirus disease 2019 (COVID-19)Distance teachingDistance educationeducation030232 urology & nephrologyUrologylcsh:Surgery03 medical and health sciences0302 clinical medicineCOVID-19; pandemic; residency; residents; urologyMultidisciplinary approachPandemicMedicineresidenturologyOriginal ResearchSettore MED/24 - UROLOGIAbusiness.industrySocial distancepandemicCOVID-19lcsh:RD1-811Settore MED/24030220 oncology & carcinogenesisresidentsSurgeryurology; residency; residents; pandemic; COVID-19businessresidency
researchProduct

Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey

2020

Telemedicinemedicine.medical_specialtytelemedicine; COVID-19; inflammatory bowel disease; Aftercare; Betacoronavirus; Hospitalization; Humans; Infection Control; Italy; Mass Screening; Organizational Innovation; Remote Consultation; Surveys and Questionnaires; Coronavirus Infections; Hospital Units; Inflammatory Bowel Diseases; Pandemics; Pneumonia Viral; TelemedicinePneumonia ViralAftercareInflammatory bowel diseaselaw.inventionSettore MED/12Betacoronaviruslawinflammatory bowel diseaseSurveys and QuestionnairesmedicineInfection controlImmunology and AllergyHumansMass ScreeningViralLetters to the EditorPandemicsMass screeningAcademicSubjects/MED00260Remote ConsultationCOVID-19; inflammatory bowel disease; telemedicine; Aftercare; Betacoronavirus; COVID-19; Hospitalization; Humans; Infection Control; Italy; Mass Screening; Organizational Innovation; Remote Consultation; SARS-CoV-2; Surveys and Questionnaires; Coronavirus Infections; Hospital Units; Inflammatory Bowel Diseases; Pandemics; Pneumonia Viral; TelemedicineInfection Controlbusiness.industrySARS-CoV-2Remote ConsultationGastroenterologyCOVID-19PneumoniaBiological productmedicine.diseaseInflammatory Bowel DiseasesIntensive care unitOrganizational InnovationTelemedicineHospitalizationDiarrheaItalyEmergency medicinemedicine.symptomtelemedicine; COVID-19; inflammatory bowel diseasebusinessCoronavirus InfectionsHospital UnitsInflammatory Bowel Diseases
researchProduct

Teoloģijas un reliģijpētniecības sekcija “Krīzes un reliģija”: tēžu krājums

2021

Ticamības krīze - Latvijas luterāņu baznīcaKārlis IrbeLatvijas Baptistu draudzes - krīzes situācijā:HUMANITIES and RELIGION::Religion/Theology [Research Subject Categories]ticības krīzeKopīgais labumsRomas katoļu baznīcaPāvests FrancisksTeoloģija - Covid-19 pandēmijas laikāaktīvā atvērtā domāšanaSakramentālā praksepacietība
researchProduct

La crise du Covid-19, un changement stratégique pour le tourisme ? L’analyse de la recherche internationale

2020

Article professionnel; International audience; Le confinement mondial lié au Covid-19 a été propice aux réflexions et échanges entre chercheurs du monde entier, que cet article synthétise. À court terme, la crise du coronavirus aura des effets destructeurs sur l’industrie du tourisme. Toutefois, les chercheurs pensent voire espèrent que la crise va transformer radicalement les mobilités à l’échelle mondiale et que le tourisme va devenir plus responsable et plus durable. La crise ne révolutionnera pas l’industrie du tourisme du jour au lendemain, mais elle induira des changements opérationnels, et stratégiques, à plusieurs niveaux.

Tourisme[SHS.GESTION]Humanities and Social Sciences/Business administrationCrise du Covid-19[SHS.GESTION] Humanities and Social Sciences/Business administration
researchProduct

The Italian Version of the Adult Vaccine Hesitancy Scale (aVHS) for the Working-Age Population: Cross-Cultural Adaptation, Reliability, and Validity

2022

The adult Vaccine Hesitancy Scale (aVHS) is valid and reliable for evaluating attitudes toward vaccine preventable diseases (VPDs). The aim of the present study was to evaluate the cross-cultural adaptation, reliability, and validity of the Italian version of the aVHS. After cross-cultural adaptation of the aVHS, internal consistency (IC), intra-class correlation (ICC), and content validity (S-CVI) were evaluated through a survey on 160 workers. Results of the ICC were analyzed on questionnaires administered twice at a distance of two months and revealed a satisfactory reproducibility (0.87). The IC of the aVHS was assessed by the Cronbach alpha coefficient test, with a result of 0.94, demo…

Vaccine preventable diseasePharmacologySARS-CoV-2VaccinationImmunologyCOVID-19vaccination; workplace; SARS-CoV-2; vaccine hesitancy; Italy; worker; COVID-19; vaccine preventable diseaseSARS‐CoV‐2Infectious DiseasesItalyCOVID‐19Drug DiscoveryWorkerPharmacology (medical)WorkplaceVaccine hesitancyVaccines
researchProduct

Early and Longitudinal Humoral Response to the SARS-CoV-2 mRNA BNT162b2 Vaccine in Healthcare Workers: Significance of BMI, Adipose Tissue and Muscle…

2022

Background: This study aimed to investigate the early and longitudinal humoral response in Healthcare Workers (HCWs) after two doses of the BNT162b2 vaccine and to assess the association between metabolic and anthropometric parameters and the humoral response after vaccination. Methods: The study included 243 fully vaccinated HCWs: 25.50% previously infected with SARS-CoV-2 (with prior history of COVID-19—PH) and 74.40%—uninfected, seronegative before the first vaccination (with no prior history of COVID-19—NPH). IgG antibodies were measured, and sera were collected: prior to the vaccination, 21 days after the first dose, and 14 days and 8 months after the second dose. Res…

VaccinesCOVID-19 VaccinesSARS-CoV-2Health PersonnelMusclesCOVID-19Body Mass IndexInfectious DiseasesAdipose TissueMuscular DiseasesVirologyHumansIgG antibody; SARS-CoV-2; COVID-19; healthcare workers; health care professionals; COVID-19 vaccine; BNT162 vaccine; adipose tissue; body composition; immunizationRNA MessengerBNT162 VaccineViruses-Basel
researchProduct

Who can go back to work when the COVID-19 pandemic remits?

2020

AbstractThis paper seeks to determine which workers affected by lockdown measures can return to work when a government decides to apply lockdown exit strategies. This system, which we call Sequential Selective Multidimensional Decision (SSMD), involves deciding sequentially, by geographical areas, sectors of activity, age groups and immunity, which workers can return to work at a given time according to the epidemiological criteria of the country as well as that of a group of reference countries, used as a benchmark, that have suffered a lower level of lockdown de-escalation strategies. We apply SSMD to Spain, based on affiliation to the Social Security system prior to the COVID-19 pandemic…

Viral DiseasesEpidemiologyPathology and Laboratory MedicineGeographical locations0302 clinical medicineReturn to WorkMedical ConditionsPandemicMedicine and Health Sciences030212 general & internal medicineChildEpidemiology ; COVID-19 ; Virus testing ; Serotology ; Age groups ; Spain ; Death rates ; PandemicsVirus TestingAged 80 and overeducation.field_of_studyMultidisciplinaryExit strategyQRMiddle AgedEuropeInfectious DiseasesSerologyWork (electrical)Child PreschoolMedicineCoronavirus InfectionsResearch ArticleAdultCoronavirus disease 2019 (COVID-19)AdolescentDeath RatesScience030231 tropical medicinePopulationDecision MakingPneumonia ViralDecision tree03 medical and health sciencesBetacoronavirusYoung AdultPopulation MetricsDiagnostic MedicineBenchmark (surveying)HumansEuropean UnioneducationPandemicsAgedGovernmentActuarial sciencePopulation BiologySARS-CoV-2Decision TreesInfant NewbornCOVID-19InfantBiology and Life SciencesCovid 19Replication (computing)Social securitySpainAge GroupsPeople and PlacesPopulation GroupingsBusiness
researchProduct

To defer or not to defer? A German longitudinal multicentric assessment of clinical practice in urology during the COVID-19 pandemic

2020

PLOS ONE 15(9), e0239027 (2020). doi:10.1371/journal.pone.0239027

Viral DiseasesUrologistsMedizinCancer TreatmentGermanMedical ConditionsRobotic Surgical ProceduresGermanySurveys and QuestionnairesPandemicMedicine and Health SciencesResponse rate (survey)MultidisciplinaryProstate CancerQRProstate DiseasesHospitalizationInfectious DiseasesSurgical OncologyOncologylanguageMedicineCoronavirus InfectionsResearch ArticleUrologic DiseasesClinical Oncologymedicine.medical_specialtyScienceHealth PersonnelUrologyPneumonia ViralMEDLINESurgical and Invasive Medical ProceduresRobotic Assisted SurgeryBetacoronavirusmedicineHumansPenile cancerRobotic surgeryBetacoronavirus; COVID-19; Coronavirus Infections; Germany; Health Personnel; Hospitalization; Humans; Internet; Pandemics; Personal Protective Equipment; Pneumonia Viral; Robotic Surgical Procedures; SARS-CoV-2; Surveys and Questionnaires; Urologic Diseases; UrologistsPandemicsPersonal Protective EquipmentPersonal protective equipmentInternetUrologic InfectionsSARS-CoV-2COVID-19 ; Urology ; Surgical and invasive medical procedures ; Urologic infections ; Surgical oncology ; Robotic assisted surgery ; Cancer treatment ; Prostate cancerGenitourinary Infectionsbusiness.industryGeneral surgeryCOVID-19Cancers and NeoplasmsRobotic Surgical ProceduresCovid 19medicine.diseaselanguage.human_languageGenitourinary Tract TumorsClinical MedicinebusinessPLOS ONE
researchProduct

COVID-19 Pandemic: Prevention and protection measures to be adopted at the workplace

2020

Introduction: SARS-CoV-2, identified in Wuhan, China, for the first time in December 2019, is a new viral strain, which has not been previously identified in humans; it can be transmitted both by air and via direct and indirect contact; however, the most frequent way it spreads is via droplets. Like the other viruses belonging to the same family of coronaviruses, it can cause from mild flu-like symptoms, such as cold, sore throat, cough and fever, to more severe ones such as pneumonia and breathing difficulties, and it can even lead to death. Since no effective specific drug therapy has been found yet, nor any vaccine capable of limiting the spread of this pathogen, it is important for way…

WorkGeography Planning and Development010501 environmental sciences01 natural sciencesRenewable energy sources0302 clinical medicinestrePandemicEpidemiologySore throatProtocolMedicineGE1-350030212 general & internal medicineFatigueProtectionEnvironmental effects of industries and plantsTransmission (medicine)DPIPPEmedicine.symptomenvironmental measuregloveInfectionPneumonia (non-human)medicine.medical_specialtyGlovesTJ807-830organizational measureManagement Monitoring Policy and LawTD194-195StressOccupational medicine03 medical and health sciencesPharmacotherapyEnvironmental healthTransmissiongloves ; work ; COVID-19 ; environmental measures ; infection ; occupational medicine ; Coronavirus ; PPE ; protection ; pandemic ; protocol ; organizational measures ; mask ; DPI ; prevention ; SARS-CoV-2Inanimate surfaceAerosolDroplets0105 earth and related environmental sciencesMaskPandemicRenewable Energy Sustainability and the Environmentbusiness.industrySARS-CoV-2Settore MED/44 - Medicina Del LavoroPreventionCompetitive sportCOVID-19medicine.diseaseOrganizational measurescoronaviruEnvironmental sciencesCoronavirusEnvironmental measuresSettore BIO/14 - FarmacologiadropletSuspectOccupational medicinebusiness
researchProduct

DNA damage response at telomeres boosts the transcription of SARS-CoV-2 receptor ACE2 during aging

2021

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the coronavirus disease 2019 (COVID-19), known to be more common in the elderly, who also show more severe symptoms and are at higher risk of hospitalization and death. Here, we show that the expression of the angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 cell receptor, increases during aging in mouse and human lungs. ACE2 expression increases upon telomere shortening or dysfunction in both cultured mammalian cells and in vivo in mice. This increase is controlled at the transcriptional level, and Ace2 promoter activity is DNA damage response (DDR)-dependent. Both pharmacological global DDR inhibition of ATM kin…

ace2; covid-19; dna damage response; aging; telomere; aged; angiotensin-converting enzyme 2; animals; humans; mice; sars-cov-2; aging; covid-19; dna damage; telomeremiceCoronavirus disease 2019 (COVID-19)DNA damageSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BiologySettore MED/08 - Anatomia PatologicaBiochemistry03 medical and health sciences0302 clinical medicineDownregulation and upregulationPromoter activityTranscription (biology)angiotensin-converting enzyme 2GeneticsSettore MED/05 - Patologia ClinicaReceptorhumansMolecular Biology030304 developmental biology0303 health sciencestelomereAce2 aging COVID-19DNA damage response telomereagingace23. Good healthTelomereCell biologybody regionsdna damage responseanimalsagedsars-cov-2covid-19Angiotensin-converting enzyme 2Cancer researchdna damagehormones hormone substitutes and hormone antagonists030217 neurology & neurosurgery
researchProduct